Breadcrumb

null James Tsui, B.Eng., M.Sc., MD, PhD, FRCPC

Associate Investigator, RI-MUHC, Glen site

Cancer Research Program

Assistant Professor, Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University

 

Keywords

radiotherapy • sarcoma • genitourinary cancer • gynecological cancer • medical imaging • artificial intelligence • deep learning

Research Focus

My research focuses on exploring artificial intelligence (AI) applications to enhance patient care and radiation therapy treatment. I specialize in deep-learning based auto-segmentation of medical images. Currently, I am investigating strategies to leverage AI for tailored treatment approaches, advancing personalized medicine.

Selected Publications

Click on Pubmed to see my current publications list

  • Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation Therapy. Tsui JMG, Kehayias CE, Leeman JE, Nguyen PL, Peng L, Yang DD, Moningi S, Martin N, Orio PF, D'Amico AV, Bredfeldt JS, Lee LK, Guthier CV, King MT. Int J Radiat Oncol Biol Phys. 2023 Jul 29:S0360-3016(23)07688-5. doi: 10.1016/j.ijrobp.2023.07.029. Online ahead of print. PMID: 37517600.

  • Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial. Niazi T, Nabid A, Malagon T, Bettahar R, Vincent L, Martin AG, Jolicoeur M, Yassa M, Barkati M, Igidbashian L, Bahoric B, Archambault R, Villeneuve H, Tsui JMG, Mohiuddin M. Int J Radiat Oncol Biol Phys. 2023 May 22:S0360-3016(23)00459-5. doi: 10.1016/j.ijrobp.2023.05.014. Online ahead of print. PMID: 37224928.

  • Extreme weekly locoregional hypofractionated radiation in elderly women with non-metastatic breast cancer. Rais F, Tsui JMG, Daianska A, Faye MD, Lambert C, David M, Panet-Raymond V, Azoulay M, Saidi A, Hijal T. Radiother Oncol. 2021 Sep;162:156-161. doi: 10.1016/j.radonc.2021.07.008. Epub 2021 Jul 15. PMID: 34273468.

  • The Clinical Significance of Bone Mineral Density Changes Following Long-Term Androgen Deprivation Therapy in Localized Prostate Cancer Patients. Khriguian J, Tsui JMG, Vaughan R, Kucharczyk MJ, Nabid A, Bettahar R, Vincent L, Martin AG, Jolicoeur M, Yassa M, Barkati M, Igidbashian L, Bahoric B, Archambault R, Villeneuve H, Mohiuddin M, Niazi T. J Urol. 2021 Jun;205(6):1648-1654. doi: 10.1097/JU.0000000000001646. Epub 2021 Feb 12. PMID: 33577365.

  • Combined Long-Term Androgen Deprivation and Pelvic Radiotherapy in the Post-operative Management of Pathologically Defined High-Risk Prostate Cancer Patients: Results of the Prospective Phase II McGill 0913 Study. Kucharczyk MJ, Tsui JMG, Khosrow-Khavar F, Bahoric B, Souhami L, Anidjar M, Probst S, Chaddad A, Sargos P, Niazi T. Front Oncol. 2020 Mar 12;10:312. doi: 10.3389/fonc.2020.00312. eCollection 2020. PMID: 32226774.